PCV56 PERSISTENCE WITH NEWLY-INITIATED EXTENDED-RELEASE NIACIN VERSUS OTHER LIPID MODIFYING DRUG CLASSES IN CLINICAL PRACTICE
Abstract
Authors
S Kamal-Bahl T Burke D Watson C Wentworth
S Kamal-Bahl T Burke D Watson C Wentworth
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now